Chimeric receives $1.8 M advance on FY26 R&D tax incentive
- Date and time
- Announcement type
- Periodic Reports
Show detailsHide details
- Category
- Reports
- Report codes
- 03014, 12008
- Sector
- Health Care
- Industry group
- Pharmaceuticals, Biotechnology & Life Sciences